NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy

The recent approval of oncolytic virus for therapy of melanoma patients has increased the need for precise evaluation of the mechanisms by which oncolytic viruses affect tumor growth. Here we show that the human NK cell-activating receptor NKp46 and the orthologous mouse protein NCR1 recognize the r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Virol
Autores principales: Bar-On, Yotam, Charpak-Amikam, Yoav, Glasner, Ariella, Isaacson, Batya, Duev-Cohen, Alexandra, Tsukerman, Pinchas, Varvak, Alexander, Mandelboim, Michal, Mandelboim, Ofer
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2017
Materias:
Pathogenesis and Immunity
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599737/
https://ncbi.nlm.nih.gov/pubmed/28724773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01045-17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares